#292
Andreas Struengmann & family
Overview
- Source of Wealth
- Pharmaceuticals
- Industry
- Healthcare
- Residence
- Tegernsee
- Education
- University at Buffalo (Medical Doctor)
- Marital Status
- Married
- Children
- 2
Assets
- BioNTech Sponsored ADR50,640,000 shares @ --BNTX-US
- Formycon AG2,124,000 shares @ --FYB-DE
Biography
Andreas Struengmann and twin brother Thomas were early backers of BioNTech, which partnered with Pfizer to make a vaccine for Covid-19.
The brothers cofounded generic drugmaker Hexal in 1986 and sold it to Novartis in 2005 for some $7 billion.
The brothers invest in biotech, pharma, life sciences and healthcare companies through their Zug, Switzerland-based investment firm, Santo Holding.
In 2008, they established a neuroscience research center in Frankfurt named after their father, Ernst Struengmann.
About
After studying medicine in Freiburg, Germany, Andreas worked as a doctor in South Africa.